Randomized phase III trial comparing Daunorubicin and ara-C (DA) versus ara-C, Daunorubicin, and Etoposide (ADE) as induction chemotherapy in pediatric acute myeloid leukemia (InPOG-AML-16-01) - Venkatraman Radhakrishnan; Sameer Bakhshi; Smita Kayal; Cherian Thampy; Ankit Batra; Praveen Kumar Shenoy; Hemanth Kumar; Shilpi Chaudhary; Swaminathan Rajaraman; Reema Bisht; Biswajit Dubashi; Trivadi S. Ganesan (Elsevier, 2022)